Pharmaceutical Research and Manufacturers of America & Donald Trump
6 shared events · Importance 3 · Last updated Apr 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Pharmaceutical Research and Manufacturers of America: Pharmaceutical lobby, criticized the order, representing industry concerns.
Donald Trump: Signed the executive order, driving the policy change. Faces criticism from medical and public health communities, but gains support from anti-vaccine advocates.
Aug 10, 2026 · 266 articles
Regulatory
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America (PhRMA) believes the CMS programs would be illegal and is challenging them.
Donald Trump: Donald Trump initiated the United States — Medicaid pilot program and other initiatives aimed at reducing U.S. prescription drug prices.
Apr 20, 2026 · 6 articles
Regulatory
Pharmaceutical Research and Manufacturers of America: A spokesperson for Pharmaceutical Research and Manufacturers of America>>> expressed concern that the ruling could jeopardize the 'careful balance' of the Hatch-Waxman Act, potentially undermining incentives for researching new uses for existing medicines.
Donald Trump: President Donald Trump>>>'s administration supported Hikma Pharmaceuticals>>>'s appeal to the United States — Supreme Court of the United States>>>, aligning with the goal of encouraging generic competition and potentially lowering drug prices.
Jun 04, 2026 · 7 articles
Regulatory
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America criticized the new pharmaceutical tariffs, warning they would increase healthcare costs and jeopardize U.S. investments.
Apr 02, 2026 · 23 articles
Domestic
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America, a trade association for pharmaceutical companies, states that pharmacy benefit managers and insurers create access and affordability barriers for patients.
Apr 02, 2026 · 6 articles
Domestic
Pharmaceutical Research and Manufacturers of America: Pharmaceutical Research and Manufacturers of America, a pharmaceutical company trade group, warned that Donald Trump's proposed tariffs on cutting-edge medicines could increase costs and jeopardize billions in U.S. investments.
Apr 02, 2026 · 16 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Pharmaceutical Research and Manufacturers of America and Donald Trump interact across events, view sentiment trends, and discover connected entities.
Open Dashboard